HHLA2 Expression Demonstrated by Immunohistochemistry in Non-Ductal Pancreatic Tumors

被引：0
|
作者：
de Gonzalez, Anne K. Koehne [1 ]
Yan, Han [1 ]
Su, Gloria H. [1 ]
Remotti, Helen
机构：
[1] Columbia Univ, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1896
引用
收藏
页码：681 / 681
页数：1
相关论文
共 50 条
  • [41] Rare ALK Expression but no ALK Rearrangement in Pancreatic Ductal Adenocarcinoma and Neuroendocrine Tumors
    Graham, Rondell P. D.
    Oliveira, Andre M.
    Zhang, Lizhi
    PANCREAS, 2013, 42 (06) : 949 - 951
  • [42] Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis
    Zhu, Yulan
    Chen, Junjun
    Liu, Yingting
    Zheng, Xiao
    Feng, Jun
    Chen, Xuemin
    Jiang, Tianwei
    Li, Yuan
    Chen, Lujun
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 234
  • [43] HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization
    Sun, Wenjie
    Li, Shuying
    Tang, Guiliang
    Sun, Shaoxing
    Luo, Yuan
    Bai, Rui
    Han, Linzhi
    Jiang, Xueping
    Gao, Yanping
    Huang, Zhengrong
    Zhang, Junhong
    Gong, Yan
    Xie, Conghua
    CANCER MEDICINE, 2021, 10 (15): : 5256 - 5269
  • [44] HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
    Zhou, Qiang-Hua
    Li, Kai-Wen
    Chen, Xu
    He, Hai-Xia
    Peng, Sheng-Meng
    Peng, Shi-Rong
    Wang, Qiong
    Li, Ze-An
    Tao, Yi-Ran
    Cai, Wen-Li
    Liu, Ran-Yi
    Huang, Hai
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [45] Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9
    Fu, Yuanyuan
    Zheng, Panpan
    Zheng, Xiao
    Chen, Lujun
    Kong, Caixia
    Liu, Wenzhi
    Li, Shuping
    Jiang, Jingting
    CELLULAR IMMUNOLOGY, 2023, 388
  • [46] Evaluation of GATA-3 and Estrogen Receptor Expression in Pancreatic Neuroendocrine Tumors by Immunohistochemistry
    Chaffin, Joanna M.
    Esnakula, Ashwini
    Feely, Michael
    Lai, Jinping
    Akki, Ashwin S.
    Liu, Xiuli
    Gonzalo, David Hernandez
    LABORATORY INVESTIGATION, 2018, 98 : 673 - 673
  • [47] Evaluation of GATA-3 and Estrogen Receptor Expression in Pancreatic Neuroendocrine Tumors by Immunohistochemistry
    Chaffin, Joanna M.
    Esnakula, Ashwini
    Feely, Michael
    Lai, Jinping
    Akki, Ashwin S.
    Liu, Xiuli
    Gonzalo, David Hernandez
    MODERN PATHOLOGY, 2018, 31 : 673 - 673
  • [48] HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway
    Zhou, Siqi
    Wang, Zhangding
    Zhao, Dian
    Fu, Yao
    Zhang, Shu
    Wang, Zhiping
    Zou, Xiaoping
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [49] The importance of COX-2 expression in pancreatic ductal adenocarcinomas
    Aydin, O.
    Erdamar, S.
    Karakas, N.
    Yasayan, G.
    Ozucer, B.
    Yamac, P.
    Ramazanoglu, R.
    Purisa, S.
    Dogusoy, G.
    Goksel, S.
    HISTOPATHOLOGY, 2008, 53 : 124 - 124
  • [50] Utility of Islet-1, CD99, PAX8 and β-Catenin in Fine Needle Aspiration Workup of Non-Ductal Pancreatic Neoplasms
    Velosa, C.
    Nunez, J.
    Silverman, J. F.
    MODERN PATHOLOGY, 2013, 26 : 106A - 106A
12345